MANGALAMNSEMangalam Drugs And Organics Limited· PharmaceuticalsMediumNeutral
Announced Tue, 3 Feb · 17:30 IST

Mangalam Drugs And Organics Limited has informed the Exchange about Credit Rating- New

New Credit FacilityCredit & Debt View source PDF

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Mangalam Drugs and Organics Limited has submitted a new credit rating to NSE, which typically indicates the company has either availed a new credit facility or obtained a fresh rating from a credit rating agency. The full details of the rating action — such as the rating agency, the actual rating assigned, the instrument/facility rated, and the outlook — are not included in the headline itself. Based on the filing category ('Credit Rating- New'), the most likely scenario is that the company has taken on a new loan or credit line that has been formally rated.

Likely market impact

This is a procedural disclosure and is likely neutral in the short term. Investors should look for the actual rating assigned to understand the company's creditworthiness and cost of borrowing. A strong rating on a new facility is positive, while a weak rating could raise concerns about leverage or financial health.